Comera Life Sciences Holdings, Inc.
CMRATicker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Insider trading at Comera Life Sciences Holdings, Inc. (CMRA) refers to stock transactions executed by corporate insiders—officers, directors, and shareholders owning more than 10% of the company. Over the past 90 days, 16 insiders have filed 52 transactions totaling $3.6M in trading activity. The most active insider is Charles Cherington (Executive), contributing $2.5M across 13 transactions.
Comera Life Sciences Holdings, Inc. insiders are currently net buyers of CMRA stock, showing bullish sentiment over the past 90 days. Executives have purchased $3.6M while selling $0, resulting in a positive net flow of $3.6M. This buying activity represents 100% of total transaction volume.
Comera Life Sciences Holdings, Inc. has 16 active insiders who have filed SEC Form 4 transactions in the past 90 days. Charles Cherington (Executive) leads with 13 transactions totaling $2.5M. David Soane (Executive) follows with 12 transactions worth $453.0K. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.
The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. Comera Life Sciences Holdings, Inc.'s current score of 100/100 indicates bullish insider sentiment. Scores above 60 suggest insiders are accumulating shares faster than selling, reflecting $3.6M in purchases versus $0 in sales.
The most recent insider transaction occurred on Dec 29, 2023, when Soane David (Executive) acquired 2,727,272 shares at $0.00 per share for $0. This appears to be a discretionary trade.
Based on SEC Form 4 filings from the past 90 days, CMRA insider trading sentiment is currently bullish with an Alignment Score of 100/100. The net insider flow of $3.6M reflects accumulation, with 100% of volume being purchases.
SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like Comera Life Sciences Holdings, Inc.. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At CMRA, we track all Form 4 filings—currently showing 52 transactions from 16 insiders over 90 days.
A 10b5-1 plan allows Comera Life Sciences Holdings, Inc. executives to pre-schedule stock sales when they don't possess material non-public information. At CMRA, approximately 0% of recent transactions are 10b5-1 trades. Most trading activity at CMRA appears discretionary, making insider signals more meaningful.
You can monitor Comera Life Sciences Holdings, Inc. (CMRA) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 16 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.
Insider trading at Comera Life Sciences Holdings, Inc. (CMRA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of shares. These individuals must report trades to the SEC within two business days. Currently, 16 insiders are actively trading CMRA stock, having executed 52 transactions in the past 90 days. The most active insider is Charles Cherington (Executive), with 13 transactions totaling $2.5M.
Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. Comera Life Sciences Holdings, Inc.'s current score of 100/100 indicates strong bullish sentiment with executives accumulating shares. This is calculated from $3.6M in purchases versus $0 in sales over 90 days, resulting in a net flow of $3.6M.
SEC Form 4 filings are mandatory reports that Comera Life Sciences Holdings, Inc. insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At CMRA, the most common type is "P" with 42 occurrences. The most recent Form 4 was filed on Dec 29, 2023 by Soane David.
Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At Comera Life Sciences Holdings, Inc., approximately 0% of recent transactions are executed under 10b5-1 plans, while 100% appear to be discretionary trades. The low percentage means most insider activity at CMRA represents discretionary decisions with more informational value.
Track every insider move.
Before the market reacts.
Set alerts for Comera Life Sciences Holdings, Inc. and 40,000+ other insiders.